Product Information

DORZOLAMIDE-TIMOLOL EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.8910 per ML under NDC 24208048610. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 14, 2009. Its Orange Book therapeutic-equivalence code is AT1.

DORZOLAMIDE-TIMOLOL EYE DROPS

Dorzolamide Hydrochloride and Timolol Maleate
$0.8910per ML

Strength

20; 5 mg/mL; mg/mL

NDC

24208048610

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090037

FDA Approved

7/14/2009

TE Code

AT1

On Market Since

7/14/2009

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price Statistics

The NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 41.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8910 per ML
All-time high$1.8342 (Jul 15, 2020)
All-time low$0.8203 (Dec 20, 2017)
52-week high$1.0685
52-week low$0.8853
Median price$1.1820
Average price$1.2429
Largest weekly change+19.7% (Feb 20, 2019)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.6%

1M

+0.6%

3M

-4.2%

6M

-4.6%

1Y

-16.6%

3Y

-18.1%

5Y

-40.5%

All

-41.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE-TIMOLOL EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $0.8910 per ML (NDC 24208048610), effective Aug 19, 2026.

How has the price of DORZOLAMIDE-TIMOLOL EYE DROPS changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has declined 41.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL EYE DROPS?

Since Nov 28, 2013, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has ranged from a low of $0.8203 (Dec 20, 2017) to a high of $1.8342 (Jul 15, 2020), with a median of $1.1820 per ML.

Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL EYE DROPS?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DORZOLAMIDE-TIMOLOL EYE DROPS in a comparable dosage form, but none are currently priced below it.

Who manufactures DORZOLAMIDE-TIMOLOL EYE DROPS?

DORZOLAMIDE-TIMOLOL EYE DROPS (NDC 24208048610) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.